Clostridium difficile associated disease – dramatic increase in the incidence among hospitalized patients

Autor: Correia, L, Monteiro, R, Alfaro, TM, Simão, A, Carvalho, A, Nascimento-Costa, JM

Many publications show an incidence increase of Clostridium difficile (CD) associated disease (CDAD), affecting both in- and outpatients being these recent infections more severe and difficult to treat. The aim of this retrospective study is to evalu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1504::c0776c1915db57e8ffdaedd93cbf089c
https://hdl.handle.net/10400.4/1560

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Diagnosis of Fibrotic Hypersensitivity Pneumonitis: Is There a Role for Biomarkers?

Autor: Pereira JO; Department of Pulmonology, Centro Hospitalar e Universitário de Coimbra, 3000-561 Coimbra, Portugal.; Faculty of Medicine, University of Coimbra, 3000-504 Coimbra, Portugal., Fernandes V; Department of Pulmonology, Centro Hospitalar do Baixo Vouga, 3810-501 Aveiro, Portugal., Alfaro TM; Department of Pulmonology, Centro Hospitalar e Universitário de Coimbra, 3000-561 Coimbra, Portugal.; Faculty of Medicine, University of Coimbra, 3000-504 Coimbra, Portugal., Freitas S; Department of Pulmonology, Centro Hospitalar e Universitário de Coimbra, 3000-561 Coimbra, Portugal.; Faculty of Medicine, University of Coimbra, 3000-504 Coimbra, Portugal., Cordeiro CR; Department of Pulmonology, Centro Hospitalar e Universitário de Coimbra, 3000-561 Coimbra, Portugal.; Faculty of Medicine, University of Coimbra, 3000-504 Coimbra, Portugal.

Publikováno v: Life (Basel, Switzerland) [Life (Basel)] 2023 Feb 17; Vol. 13 (2). Date of Electronic Publication: 2023 Feb 17.

Granulomatous-lymphocytic interstitial lung disease: an international research prioritisation.

Autor: Hurst JR; UCL Respiratory, University College London, London, UK., Abbas SH; UCL Respiratory, University College London, London, UK., Bintalib HM; UCL Respiratory, University College London, London, UK., Alfaro TM; Unit of Pneumology, Coimbra Hospital and Universitary Centre, Coimbra, Portugal., Baumann U; Paediatric Pulmonology, Allergy and Neonatology, Hanover Medical School, Hannover, Germany., Burns SO; Institute of Immunity and Transplantation, University College London, London, UK.; Dept of Immunology, Royal Free London NHS Foundation Trust, London, UK., Condliffe A; Dept of Infection, Immunity and Cardiovascular Diseases, University of Sheffield, Sheffield, UK., Davidsen JR; South Danish Centre for Interstitial Lung Diseases (SCILS), Dept of Respiratory Medicine, Odense University Hospital, Odense, Denmark., Fevang B; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Oslo, Norway.; Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway., Gennery AR; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Paediatric Immunology, Great North Children's Hospital, Newcastle upon Tyne, UK., Haerynck F; Dept of Pediatric Pulmonology and Immunology, Jeffrey Modell Foundation Diagnostic and Research Centre, PID Research lab, Ghent University Hospital, Ghent University, Ghent, Belgium., Jacob J; UCL Respiratory, University College London, London, UK.; Centre for Medical Image Computing, University College London, London, UK., Jolles S; Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, UK., Lamers O; Dept of Parasitology, Leiden University Medical Center, Leiden, The Netherlands., Bergeron A; Université de Paris, Hôpital Saint-Louis, AP-HP, Pulmonology Dept, Paris, France., Malphettes M; Immunology Dept, Inserm U1126, Hôpital Saint-Louis, APHP, Paris, France., Meignin V; Dept of Pathology, Hôpital Saint-Louis, APHP, Paris, France., Milito C; Dept of Molecular Medicine, Sapienza University of Rome, Rome, Italy., Milota T; Second Faculty of Medicine, Charles University, Prague, Czech Republic.; Motol University Hospital, Prague, Czech Republic., Pergent M; International Patient Organisation for Primary Immunodeficiencies, Brussels, Belgium., Prasse A; Dept of Pulmonology, Hannover Medical School, Hannover, Germany.; DZL BREATH, Hannover, Germany.; Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany., Quinti I; Dept of Molecular Medicine, Sapienza University of Rome, Rome, Italy., Renzoni E; Interstitial Lung Disease Unit, Royal Brompton Hospital/Imperial College London, London, UK., Sediva A; Second Faculty of Medicine, Charles University, Prague, Czech Republic.; Motol University Hospital, Prague, Czech Republic., Stolz D; University Hospital Basel, Clinic of Respiratory Medicine and Pulmonary Cell Research, Basel, Switzerland., Smits B; Dept of Pediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital, UMC Utrecht, Utrecht, The Netherlands., Strauss F; dsai e.V. Patientenorganisation fuer angeborene Immundefekte, Schnaitsee, Germany., van de Ven AAJM; Dept of Internal Medicine and Allergology, University Medical Centre Groningen, Groningen, The Netherlands.; Dept of Rheumatology and Clinical Immunology, University Medical Centre Groningen, Groningen, The Netherlands., van Montfrans J; Dept of Internal Medicine and Allergology, University Medical Centre Groningen, Groningen, The Netherlands.; Dept of Rheumatology and Clinical Immunology, University Medical Centre Groningen, Groningen, The Netherlands., Warnatz K; Dept of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Center for Chronic Immunodeficiency, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Publikováno v: ERJ open research [ERJ Open Res] 2021 Dec 06; Vol. 7 (4). Date of Electronic Publication: 2021 Dec 06 (Print Publication: 2021).

Educational aspects of rare and orphan lung diseases.

Autor: Alfaro TM; Unit of Respiratory Medicine, Coimbra Hospital and University Centre, Coimbra, Portugal. alfarotm@gmail.com.; ERS Early Career Members Committee Representative for Assembly 12: Interstitial Lung Diseases, Lausanne, Switzerland. alfarotm@gmail.com., Wijsenbeek MS; Department of Respiratory Medicine, Erasmus Medical Centre, University Hospital Rotterdam, Rotterdam, The Netherlands.; European Reference Network on Rare Lung Diseases (ERN-LUNG), Frankfurt am Main, Germany.; ERS Secretary of Group 12.01-Idiopathic Interstitial Pneumonias, Lausanne, Switzerland., Powell P; European Reference Network on Rare Lung Diseases (ERN-LUNG), Frankfurt am Main, Germany.; European Lung Foundation, Sheffield, UK., Stolz D; Clinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital Basel, Basel, Switzerland.; ERS Immediate Past Education Council Chair, Lausanne, Switzerland., Hurst JR; UCL Respiratory, University College London, London, UK., Kreuter M; European Reference Network on Rare Lung Diseases (ERN-LUNG), Frankfurt am Main, Germany.; Centre for Interstitial and Rare Lung Diseases, Pneumology and Respiratory Care Medicine, Thoraxklinik, University of Heidelberg, Heidelberg, Germany.; German Centre for Lung Research, Heidelberg, Germany.; ERS Chair of Group 12.01-Idiopathic Interstitial Pneumonias, Lausanne, Switzerland.; ERS Elect Early Career Members Committee Representative for Assembly 12: Interstitial Lung Diseases, Lausanne, Switzerland., Moor CC; Department of Respiratory Medicine, Erasmus Medical Centre, University Hospital Rotterdam, Rotterdam, The Netherlands.; ERS Elect Early Career Members Committee Representative for Assembly 12: Interstitial Lung Diseases, Lausanne, Switzerland.

Publikováno v: Respiratory research [Respir Res] 2021 Mar 24; Vol. 22 (1), pp. 92. Date of Electronic Publication: 2021 Mar 24.